Free Access
J Extra Corpor Technol
Volume 54, Number 3, September 2022
Page(s) 235 - 238
Published online 15 September 2022
  1. Zhang Y, Xiao M, Zhang S, et al. Coagulopathy and antiphospholipid antibodies in patients with Covid-19. N Engl J Med. 2020;382:e38. [CrossRef] [PubMed] [Google Scholar]
  2. Thachil J. The versatile heparin in COVID-19. J Thromb Haemost. 2020;18:1020–2. [CrossRef] [Google Scholar]
  3. Tang N, Bai H, Chen X, et al. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. J Thromb Haemost. 2020;18:1094–9. [CrossRef] [Google Scholar]
  4. Lai CC, Shih TP, Ko WC, et al. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges. Int J Antimicrob Agents. 2020;55:105924. [CrossRef] [Google Scholar]
  5. Aslam S, Mehra MR. COVID-19: Yet another coronavirus challenge in transplantation. J Heart Lung Transplant. 2020;39:408–9. [CrossRef] [Google Scholar]
  6. Parzy G, Daviet F, Persico N, et al. Prevalence and risk factors for thrombotic complications following venovenous extracorporeal membrane oxygenation: A CT scan study. Crit Care Med. 2020;48:192–9. [CrossRef] [PubMed] [Google Scholar]
  7. Boissier F, Katsahian S, Razazi K, et al. Prevalence and prognosis of cor pulmonale during protective ventilation for acute respiratory distress syndrome. Intensive Care Med. 2013;39:1725–33. [CrossRef] [PubMed] [Google Scholar]
  8. Reis Miranda D, van Thiel R, Brodie D, et al. Right ventricular unloading after initiation of venovenous extracorporeal membrane oxygenation. Am J Respir Crit Care Med. 2015;191:346–8. [CrossRef] [PubMed] [Google Scholar]
  9. Jerjes-Sanchez C, Ramírez-Rivera A, de Lourdes García M, et al. Streptokinase and heparin versus heparin alone in massive pulmonary embolism: A randomized controlled trial. J Thromb Thrombolysis. 1995;2:227–9. [CrossRef] [PubMed] [Google Scholar]
  10. Wan S, Quinlan DJ, Agnelli G, et al. Thrombolysis compared with heparin for the initial treatment of pulmonary embolism: A meta-analysis of the randomized controlled trials. Circulation. 2004;110:744–9. [CrossRef] [PubMed] [Google Scholar]
  11. Quezada CA, Bikdeli B, Barrios D, et al. Meta-analysis of prevalence and short-term prognosis of hemodynamically unstable patients with symptomatic acute pulmonary embolism. Am J Cardiol. 2019;123:684–9. [CrossRef] [Google Scholar]
  12. Kanter DS, Mikkola KM, Patel SR, et al. Thrombolytic therapy for pulmonary embolism. Frequency of intracranial hemorrhage and associated risk factors. Chest. 1997;111:1241–5. [CrossRef] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.